Paxlovid – the newest drug being rolled out to treat the wu-flu virus, can cause life threatening effects, especially for those who are taking other common medications.
In a surprise move, the Food and Drug Administration (FDA) actually admitted this truth.
The drug, which has been developed by Pfizer, was granted emergency use authorization on December 22, but since then, the agency has admitted that the interactions paxlovid has with medications like statins, blood thinners and some antidepressants, can cause serious and life-threatening reactions in patients who take it.
The FDA’s director for Drug and Evaluation and Research, Patricia Cavazzoni, said that paxlovid would provide an additional tool to fight the emergence of any new variants and this was the reason for the EUA being granted.
“Paxlovid promises to make antiviral treatment more accessible to patients who are at risk for progression to severe COVID 19,” Cavazzoni said.
By November, the Biden Administration had already purchased upwards of 10 million courses of paxlovid. Pfizer pocketed another $5 billion in profits after they made an agreement.
The medication is dangerous to anyone who suffers from severe kidney disease or liver disease as the paxlovid treatment consists of two antivirals, nirmatrevir and ritonavir.
Ritonavir suppresses a key enzyme that metabolizes many medications and is called CYP3A.
This enzyme also metabolizes nirmatrevir, but when it is given while other medications are present, that are also metabolized by CYP3A, the ritonavir can cause those medications to reach toxic levels.
In December, Pfizer announced that the treatment would reduce the risk of hospitalization and slash deaths by a whopping 89 percent.
On December 8, Pfizer CEO, Albert Bourla told CNBC that shipments have already arrived in the United States.
The new treatment alleges it would successfully treat patients if taken within three days of being suspected of being covid positive – the issue here is, if they turn out to not be COVID positive, they’ve now taken potentially toxic drugs for no good reason at all.
Doctors and researchers say that this treatment would treat the omicron variant, but would not stop the transmission.
The United Kingdom’s drug regulator Medicines and Healthcare products Regulatory Agency (MHRA), gave approval for paxlovid to be given to patients 18 years or older if they are at risk of developing severe disease.
“this treatment could be life-saving,” said June Raine, chief executive of the MHRA.
Omicron is rapidly spreading through the UK and this has reduced the options for effective treatment. Although researchers who originally identified omicron in Africa, said the omicron variant was mild, much like the common cold.
The medical industry, of course is looking to further enrich themselves, has whipped the public up into a frenzy, causing panic in the general population.
These new antivirals would also not be needed at all if doctors were able to prescribe Ivermectin or Hydroxychloroquine – cheap drugs that have been used for decades. But obviously, Pfizer isn’t going to make billions from a patent they don’t own.